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Introduction
Armed conﬂ  ict and HIV infection have 
had a profound impact on the societies 
of sub-Saharan Africa. The number of 
countries engaged in armed conﬂ  ict has 
ﬂ  uctuated, totalling 24 African states 
in 2004 [1]; most of these conﬂ  icts are 
intrastate and chronic. The region also 
bears the world’s highest burden of 
HIV, with more than 25 million people 
reported to be infected [2]. 
Although the inter-relationship 
between HIV and conﬂ  ict is 
increasingly clear [3–6], the effect 
of conﬂ  ict and instability on the 
incidence and prevalence of HIV can 
be unpredictable [6]. Much of the 
evidence on risks is unreliable, and 
conﬂ  ict may both protect a population 
from HIV by isolating communities 
from the spread of infection, and 
increase an individual’s risk through 
displacement, sexual violence, and 
breakdown of communities and health-
care institutions. 
Despite an often signiﬁ  cant burden 
of HIV-related mortality and morbidity, 
few HIV care programmes have been 
attempted in conﬂ  ict regions. There is 
a perception that it will be too difﬁ  cult 
to perform safely and effectively, and 
that HIV prevention and treatment 
are of secondary importance to 
concerns such as food, shelter, water 
and sanitation, basic medical care, 
and personal security. As outlined in 
Table 1, providing HIV care in conﬂ  ict 
settings involves additional obstacles to 
those generally encountered in other 
resource-limited settings. 
This paper describes lessons from 
three years’ experience of providing 
HIV care, including antiretroviral 
therapy (ART), to a conﬂ  ict-affected 
population in the Democratic Republic 
of the Congo (DRC). 
Chronic Conﬂ  ict in the Bukavu 
Region 
Bukavu is a city of 600,000 inhabitants 
located on the southern shore of 
Lake Kivu in eastern DRC, bordering 
Rwanda (Figure 1). The region has 
experienced chronic conﬂ  ict since 
1996, involving the neighbouring states 
of Rwanda, Uganda, and Burundi, as 
well as numerous internal guerrilla 
armies. The conﬂ  ict in DRC is 
estimated to have resulted in more than 
3.9 million deaths between 1998 and 
2004 [7]. Despite a 2001 peace accord 
and elections held in July 2006, peace 
in the region remains elusive [8].
Design of the Médecins Sans 
Frontières HIV Programme in 
Bukavu
By the late 1990s, HIV prevalence in 
Bukavu was estimated at 4%–9% [9]. 
The Médecins Sans Frontières (MSF) 
project was initiated in 2000 to provide 
treatment for those infected with HIV 
and to help reduce the rate of HIV 
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Table 1. Obstacles to Providing HIV Care in Resource-Limited Chronic Conﬂ  ict Settings
Type of Obstacle Examples of Obstacle
Medical system–related obstacles •  Limited (or absent) health infrastructure 
•  Limited (or absent) human resources (persons and skills)
• Limited  ﬁ  nancial resources
•  Limited political leadership, will, coordination, or competency
Population-related obstacles •  Poverty
• Stigma
•  Limited HIV awareness/understanding
Conﬂ  ict-related obstacles  •  Instability of security 
o  Interruption in programme continuity/safety
•  Instability of populations 
o  Increased migration or population movement
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transmission. Bukavu was chosen for 
this project because it had a high HIV 
prevalence, and was an area of relative 
calm in a region of conﬂ  ict.
The programme began with 
treatment of sexually transmitted 
infections and HIV prevention activities 
focusing on outreach education and 
condom promotion for high-risk 
groups: commercial sex workers, taxi/
truck drivers, military personnel, and 
youth. These activities were conducted 
in partnership with the Ministry of 
Health and local non-governmental 
organisations. In 2002, the ﬁ  rst of 
three voluntary counselling and 
testing (VCT) sites and the ﬁ  rst of 
two HIV clinics opened. HIV testing 
was conducted using two parallel 
rapid diagnostic tests, initially with 
nurses and other para-medical staff, 
and later with lay persons, trained as 
VCT and adherence counsellors. The 
clinics provided free-of-charge basic 
primary medical care, prophylaxis and 
treatment for opportunistic infections 
including tuberculosis, prevention of 
mother-to-child transmission of HIV, 
post-exposure prophylaxis for victims 
of sexual violence, nutritional support, 
and inpatient and home-based care. In 
October 2003, the programme began 
providing ART—the ﬁ  rst service to do 
so free of charge in eastern DRC. 
Most patients were started on generic 
ﬁ  xed-dose combination ART with 
stavudine, lamivudine, and nevirapine. 
Selection criteria were based on 
2003 World Health Organization 
guidelines [10], and all those who were 
eligible and consented to treatment 
received ART. All patients presenting 
to the clinic were eligible for the 
programme, including those from as 
far as neighbouring Rwanda. Before 
starting ART, patients attended three 
workshops (usually in groups of 10–20) 
on HIV and how ART medications 
work, common side effects and how 
to overcome them, the importance 
of adherence, and drug resistance. 
Nurses, VCT counsellors, physicians, 
and experienced patients jointly 
contributed to the adherence sessions. 
More recently, patients also receive 
speciﬁ  c education related to planning 
for episodes of insecurity (described 
below); they are also educated about 
what to do if active conﬂ  ict causes a 
disruption to the programme. Regular 
group adherence workshops continue 
after commencement of ART.
Each clinic is staffed by two 
physicians, four nurses, and several 
lay support workers; the physician 
to patient ratio is currently 1:500, 
and continues to rise. As such, 
physician responsibilities, including 
the initiation and management of 
ART, are increasingly delegated to 
nurses. The clinic is supported by a 
central laboratory with automated 
haematology, biochemistry, and CD4 
cell count capacity. 
Programme Outcomes 
Between May 2002 and January 2006, 
11,076 people had received VCT, of 
whom 19% were HIV positive. Of those 
who tested HIV positive, 94% (1,868 
patients) received follow-up care in the 
HIV clinics (Figure 2).
By January 2006, 494 (26%) patients 
had commenced ART. Of these, 66% 
were female with a median age of 
37 years (interquartile range [IQR] 
30–43) and median weight of 51 kg 
(IQR 44–58). At baseline, 3% were 
in clinical stage I of HIV (as deﬁ  ned 
by the World Health Organization’s 
disease staging system), 12% in stage 
II, 49% in stage III, and 34% in stage 
IV; baseline median CD4 count was 
123 cells/mm3 (IQR 57–195). Good 
ART adherence, deﬁ  ned as missing 
less than 5% of pills at last clinic visit 
doi:10.1371/journal.pmed.0040129.g001 
Figure 1. Map of Bukavu, South Kivu, DRC
Box 1. Patient Testimony 
Patient 1 
Followed in the clinic since 2002, on ART 
since December 2003. Lives in Rwanda. 
When the ﬁ  ghting started, I thought 
that it was the end of our lives. I had 
only treatment for three days and ﬁ  ve 
days of security. I had interrupted my 
treatment for two days when another 
patient arrived with the treatments sent 
by MSF. I was afraid it was the end of my 
life because more than just the [lack] of 
medications, I was very sick and I had to 
be hospitalised with fever and vomiting. 
It is very important to have the treatment. 
Patient 2
Followed in the clinic since May 2003, and 
on ART since December 2003. 
I heard gun ﬁ  re all through the night. 
When I had only ﬁ  ve pills left I lost my 
appetite and felt desperate…but despite 
the uncertainty I continued to take my 
treatment at the correct hour… When I 
had only one pill left I had the courage to 
go out and seek some more treatment. I 
went to see [my] nurse [at her home] who 
informed me that she would be able to 
distribute ARVs; with that I had a month’s 
worth of treatment. If we have to give up 
this treatment we will return to how we 
were at the start, sick. 
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and measured by pill counts, was 
achieved by 99% of patients. 
Table 2 shows the outcomes on ART 
compared to other cohorts in stable 
resource-limited settings (ART-LINC) 
and resource-rich settings (ART-CC) 
[11]. The ART-LINC cohort included 
patients from 18 ART programmes in 
Africa, Asia, and South America, and 
the ART-CC cohort included patients 
from 12 ART programmes in Europe 
and North America. CD4 gains at six 
months were similar in all three groups, 
and the 12-month mortality and loss 
to follow-up rates compare favourably 
to the stable ART resource-poor 
programmes represented in the ART-
LINC cohort. Adherence rate, weight 
gain, CD4 gain, mortality, and loss to 
follow-up rates all compare favourably 
to other reported HIV treatment 
programmes in non-conﬂ  ict, resource-
limited settings [11–16]. 
Acute Conﬂ  ict in the City of Bukavu 
(May–June 2004) 
Most armed conﬂ  icts in this region 
have occurred outside Bukavu. 
However, on May 26, 2004, rebel forces 
from within the Congolese military 
invaded the city, resulting in intense 
ﬁ  ghting for 13 days. During this period 
hundreds of civilians were killed, 
thousands ﬂ  ed across the border into 
Rwanda, and many women were raped 
[17].
During the crisis, movement of staff 
and patients was curtailed, and all 
expatriate MSF staff were evacuated 
from the city. Basic HIV clinic and 
hospital functions were maintained 
during most of the conﬂ  ict period 
by a Congolese nurse who lived 
nearby, although the clinic remained 
inaccessible to many due to distance 
and insecurity. Communication during 
this time was difﬁ  cult but continued 
via a radio broadcast and “word of 
mouth”. The MSF pharmacy was not 
looted.
Up until the start of the crisis, 66 
patients had initiated ART, and these 
patients experienced the following 
outcomes: 
•  14 had sufﬁ  cient medication 
supplies and did not need to come 
to the clinic; 
•  three were hospitalised and had 
ready access to medication; 
•  41 came for their antiretroviral 
(ARV) drugs during the crisis 
period; 
•  three were able to collect their 
ARVs in Rwanda in collaboration 
with another MSF mission; 
• ﬁ  ve (of whom four were displaced 
from Bukavu) had a signiﬁ  cant 
interruption in their ART. 
All eventually re-established contact 
with the clinic and returned to 
treatment.
Eight months after the conﬂ  ict, a 
focus group was held involving ﬁ  ve of 
the affected patients and two nursing 
staff. They were selected using a 
stratiﬁ  ed simple sampling method to 
represent the experiences of being 
displaced or not displaced, with or 
without treatment interruption. 
Patients reported physical and 
mental hardship, illness, geographic 
displacement, limitations in movement, 
and the threat of violence and food 
scarcity. All patients ﬁ  rmly believed 
that their lives depended on remaining 
adherent to their ART (Box 1). 
Preparing for Instability: 
The Importance of Contingency 
Planning
Our experience has shown us that one 
of the keys to successful provision of 
ART in conﬂ  ict settings is preparation 
for disruption. Programmes should 
establish contingency plans to enable 
staff and patients to react as efﬁ  ciently 
as possible should the conﬂ  ict worsen. 
Key areas to be considered as part of 
contingency planning are: 
1. Education. Patient education 
must stress the importance of excellent 
ART adherence—in particular the 
importance of not reducing drug 
dosing to make stocks last longer if 
supplies are threatened. However, 
patients should understand that a 
forced ART interruption, if managed 
appropriately, will usually not result 
in ART resistance, and they should 
be educated on how to interrupt 
treatment if necessary (see below). 
Patients also need to be informed 
about contingency plans during periods 
of acute instability, including the 
mechanisms for supply of medication 
and ongoing clinical support. 
2. Human resources capacity. All 
medical staff should be well grounded 
in the basics of HIV management 
(including ART) so that they can ﬁ  ll 
any human resources gaps that occur 
during acute conﬂ  ict. The goal is to 
create multi-skilled staff that can keep a 
basic programme running if physicians 
or other medical staff are evacuated. 
3. Communication networks. A pre-
established communication network 
between health staff and patients 
should be established. This may involve 
such activities as radio broadcasts, 
church groups, or posters. 
4. Emergency drug stocks and 
“washout medications”. An additional 
15–30 days emergency stock of 
ARVs and prophylactic medications 
can be given to each patient. They 
should be brought to the clinic on 
each visit so that their quantity and 
expiration dates can be monitored. 
Additionally, a “washout” drug stock 
can be supplied. Patients on a regimen 
containing non-nucleoside reverse 
transcriptase inhibitors (NNRTIs) can 
be supplied with a seven-day “washout” 
course of whichever two nucleoside 
reverse transcriptase inhibitor drugs 
doi:10.1371/journal.pmed.0040129.g002
Figure 2. Monthly Number of People Undergoing VCT, Testing HIV Positive, and Enrolling in 
the HIV Clinic
May 2007  |  Volume 4  |  Issue 5  |  e129PLoS Medicine  |  www.plosmedicine.org 0797
they usually take (i.e., lamivudine 
and zidovudine, or stavudine and 
lamivudine) which they should take 
after their regular ART is ﬁ  nished. This 
will reduce the likelihood of NNRTI 
resistance during the period of effective 
NNRTI monotherapy brought about by 
its long half-life [18]. 
5. Secure drug storage. HIV 
medications may be a target for looting 
or vandalism. Drug stocks should 
be divided and stored securely and 
discreetly at different locations to 
minimise the impact of such an event. 
Stock size at programme levels should 
be kept to the minimum necessary in 
very unstable areas.
6. Decentralisation of care. 
Decentralisation of clinical services 
throughout the treatment area will 
reduce travel requirements, making it 
easier and safer for staff and patients to 
access the clinics in times of insecurity. 
7. Cooperation with HIV treatment 
facilities in neighbouring regions. 
Relationships with other programmes 
that can provide ART in neighbouring 
regions should be established. An 
agreement of mutual support between 
organisations may be critical for 
the care of displaced patients or for 
emergency access to medication in case 
supplies are stolen or destroyed. 
8. Treatment information cards and 
duplicate medical records. All patients 
should be provided with a personal 
identiﬁ  cation card which lists their 
antiretroviral medications and other 
signiﬁ  cant medical information such as 
co-morbidities, medical allergies, and 
CD4 counts. This documentation is 
useful if the patient becomes displaced 
and seeks treatment elsewhere or if 
the clinic medical records are lost 
or destroyed as a result of looting. 
Duplicate medical records should be 
securely stored separately from the 
clinic site. 
9. Integration with other services. A 
partnership with government health 
services may help ensure access to 
authorities and supply chains in an 
acute conﬂ  ict situation. Importantly, 
communication links need to be 
established with all sides of the conﬂ  ict. 
These relationships may also provide 
some protection from looting in times 
of conﬂ  ict. Ideally, the perceived 
beneﬁ  ts of the programme are such 
that the community as a whole, 
including government, civil society, 
and military, are willing to support it 
despite the conﬂ  ict.
Discussion
The HIV project in Bukavu shows 
that the provision of comprehensive 
HIV care, including ART, in chronic 
conﬂ  ict settings can be feasible and 
effective, with early treatment outcomes 
similar to those in HIV projects in 
non-conﬂ  ict settings. However, it 
should be noted that these results 
have been achieved with the support 
and resources of an international non-
governmental organisation (MSF), 
in an urban setting, with the episode 
of disruption occurring early in the 
programme, and thus similar results 
in conﬂ  ict settings may not always 
be possible. Nevertheless, the key 
elements of contingency planning for 
care delivery in conﬂ  ict settings are not 
resource-intense and we believe they 
can generally be applied to most care 
programmes.
While assumptions about instability 
in DRC have prevented most from 
attempting to provide HIV treatment, 
the Bukavu project experienced only 
one signiﬁ  cant episode of disruption 
over a three-year period. An important 
insight from our experience is that 
the label of “chronic conﬂ  ict” should 
not be assumed to mean frequent 
instability. In fact, Bukavu’s pattern 
of conﬂ  ict characterised by periods of 
relative calm punctuated by episodes 
of acute insecurity is quite typical for 
many African conﬂ  icts [19], and many 
of the lessons learnt in the Bukavu 
programme are currently being applied 
by MSF in other conﬂ  ict-affected 
settings.
Although episodes of insecurity 
can destabilise ART programmes, 
putting patients at increased risk of 
ART interruption and drug resistance, 
contingency planning and a managed 
treatment interruption contingency 
plan can minimise this risk. Given the 
uncertainties facing HIV programmes 
in many resource-limited settings—the 
risk of ruptures in drug supply due to 
mismanagement, insufﬁ  cient funding, 
or lack of staff—the contingency 
planning issues discussed here may be 
relevant to more programmes than just 
those in conﬂ  ict-affected settings.
Considering the signiﬁ  cant inter-
relationships between conﬂ  ict and HIV, 
it is particularly important to target 
populations affected by both. Given 
the high numbers of HIV-positive 
individuals in many conﬂ  ict-ridden 
countries , it is not acceptable to 
wait until the conﬂ  ict is over before 
mounting a response.  
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Number of patients initiating ART  494 4,810 22,217
Number of patient years on therapy (median duration on 
ART)
235 3,744 24,310
Baseline median CD4 count [IQR] 123 [57–195] 108 [37–210] 234 [98–380]
6-month median weight gain, kg [IQR] 2.5 [0–5.5] ND ND
6-month median CD4 gain, cells/ml [IQR] 163 [82–232] 106 [43–180] 103 [32–192]
12-month mortality [95% CI] 7.9% [3.6–12.1] 6.4% [5.1–7.7] 1.8% [1.5–2.2]
12-month loss to follow-up [95% CI] 5.4% [3.2–7.5] 15% [No CI given] 5% [No CI given]
CI, conﬁ  dence interval; ND, no data.
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